CareDx, Inc Cash Conversion Cycle 2011-2026 | CDNA

Annual Cash Conversion Cycle CareDx, Inc

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
51.5	63.2	76.4	71.5	58.1	55.7	73.2	49.1	59.1	66.3	-0.498	17	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
76.4	-0.498	53.4

Quarterly Cash Conversion Cycle CareDx, Inc

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
52.5	73.1	73.3	-	73.1	62.5	70.4	-	70.2	72	74.2	-	40.5	37	71.9	-	62.9	56.2	52.8	-	59.2	77.8	73	61.3	69	73.8	62.9	37.9	44.4	52.9	41.4	21.8	22.4	22.7	22.7	30.8	34.6	31.4	33.9	32.5	30.2	30.3	32	30.8	36.9	36.2	38.2	35.4	35.7	19	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
77.8	19	48.3

Cash Conversion Cycle of other stocks in the Diagnostics research industry

Issuer	Cash Conversion Cycle	Price	% 24h	Market Cap	Country
Centogene N.V. CNTG	50.2	-	-6.23 %	$ 30.6 M	Germany
Agilent Technologies A	111	$ 117.5	2.1 %	$ 35.7 B	USA
Aspira Women's Health AWH	1.01 K	-	-6.19 %	$ 10.5 M	USA
Biocept BIOC	78.1	-	-13.05 %	$ 7.29 M	USA
Chembio Diagnostics CEMI	111	-	0.22 %	$ 16.8 M	USA
DermTech DMTK	66.7	-	-11.32 %	$ 2.94 M	USA
Exact Sciences Corporation EXAS	42.5	-	-	$ 19.8 B	USA
Akumin AKU	36.1	-	-17.87 %	$ 25.9 M	Canada
Enzo Biochem ENZ	154	-	-8.98 %	$ 14.8 K	USA
Co-Diagnostics CODX	-2.46 K	$ 1.45	5.84 %	$ 1.93 M	USA
Accelerate Diagnostics AXDX	364	-	-61.36 %	$ 2.46 M	USA
Castle Biosciences CSTL	45.9	$ 23.53	1.73 %	$ 654 M	USA
Global Cord Blood Corporation CO	184	-	-	$ 399 M	China
Genetic Technologies Limited GENE	11 K	-	-	$ 7.1 B	Australia
Genetron Holdings Limited GTH	142	-	0.12 %	$ 80.1 M	China
Charles River Laboratories International CRL	65	$ 178.34	1.53 %	$ 8.84 B	USA
PRA Health Sciences, Inc. PRAH	1.21 K	-	-	$ 10.7 B	USA
Interpace Biosciences IDXG	62.9	$ 2.2	-4.35 %	$ 9.73 M	USA
Danaher Corporation DHR	77.5	$ 195.87	3.3 %	$ 140 B	USA
Heska Corporation HSKA	138	-	-	$ 1.31 B	USA
HTG Molecular Diagnostics HTGM	104	-	-20.0 %	$ 1.06 M	USA
Illumina ILMN	142	$ 126.96	4.99 %	$ 20.2 B	USA
Fulgent Genetics FLGT	42.4	$ 15.3	6.03 %	$ 463 M	USA
Guardant Health GH	79.6	$ 82.21	4.59 %	$ 10.3 B	USA
QIAGEN N.V. QGEN	122	-	-	$ 10.6 B	Niderland
Anixa Biosciences ANIX	275	$ 2.85	5.95 %	$ 92.5 K	USA
Medpace Holdings MEDP	50.4	$ 501.23	1.56 %	$ 14.5 B	USA
Biomerica BMRA	172	$ 2.08	-2.8 %	$ 4.78 M	USA
Koninklijke Philips N.V. PHG	89	$ 28.55	0.87 %	$ 20 B	Niderland
ICON Public Limited Company ICLR	62	$ 110.37	3.33 %	$ 9.1 B	Irlanda
Laboratory Corporation of America Holdings LH	40.3	$ 264.18	1.25 %	$ 22 B	USA
Myriad Genetics MYGN	49.3	$ 4.59	5.52 %	$ 425 M	USA
NeoGenomics NEO	82.4	$ 8.0	4.03 %	$ 1.02 B	USA
Neogen Corporation NEOG	150	$ 9.14	-2.97 %	$ 1.98 B	USA
Lantheus Holdings LNTH	97.3	$ 81.67	1.34 %	$ 5.51 B	USA
Motus GI Holdings MOTS	3.45 K	-	-34.28 %	$ 263 K	Israel
Natera NTRA	81.5	$ 201.9	4.6 %	$ 19.9 B	USA
Invitae Corporation NVTA	299	-	-	$ 21.2 M	USA
Quest Diagnostics Incorporated DGX	39.5	$ 192.91	0.73 %	$ 21.4 B	USA
ENDRA Life Sciences NDRA	-1.24 K	$ 5.19	5.06 %	$ 4.08 M	USA
National Research Corporation NRC	29.4	$ 16.82	2.03 %	$ 376 M	USA
Organovo Holdings ONVO	-82.8 K	-	-2.3 %	$ 19.4 M	USA
OpGen OPGN	4.66	-	-16.95 %	$ 1.54 M	USA
Pacific Biosciences of California PACB	185	$ 1.45	8.21 %	$ 435 M	USA
Psychemedics Corporation PMD	45.3	-	-1.84 %	$ 15.3 M	USA